My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 168

    1.

    Do statins protect the kidney by reducing proteinuria?

    Tonelli M.

    Ann Intern Med. 2006 Jul 18;145(2):147-9. No abstract available. PMID: 16847297 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Meta-analysis: the effect of statins on albuminuria.

    Douglas K, O'Malley PG, Jackson JL.

    Ann Intern Med. 2006 Jul 18;145(2):117-24. Review.PMID: 16847294 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Beneficial effects of statins on the kidney.

    Afzali B, Goldsmith DJ.

    J Clin Pathol. 2004 Jul;57(7):673-4. No abstract available. Erratum in: J Clin Pathol. 2005 Jul;58(7):784. PMID: 15252929 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Time to abandon microalbuminuria?

    Ruggenenti P, Remuzzi G.

    Kidney Int. 2006 Oct;70(7):1214-22. Epub 2006 Jul 26. Review.PMID: 16871239 [PubMed - indexed for MEDLINE]Related articles

    5.

    Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

    Connor A, Tomson C.

    BMJ. 2009 Aug 20;339:b2949. doi: 10.1136/bmj.b2949. No abstract available. PMID: 19696089 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Statins in chronic renal disease]

    Ferreira SR, Rocha AM, Saraiva JF.

    Arq Bras Cardiol. 2005 Oct;85 Suppl 5:45-9. Epub 2006 Jan 2. Portuguese. PMID: 16400399 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease.

    Manca-di-Villahermosa S, Taccone-Gallucci M, Maccarrone M.

    Kidney Int. 2009 Jun;75(12):1354-5; author reply 1355. No abstract available. PMID: 19483750 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Pleiotropic effect of statins in preventing progression of chronic renal disease]

    Chrzanowski W.

    Pol Arch Med Wewn. 2003 Oct;110(4):1181-3. Review. Polish. No abstract available. PMID: 14699677 [PubMed - indexed for MEDLINE]Related articles

    9.

    HMG-CoA reductase inhibitors and the kidney.

    Campese VM, Park J.

    Kidney Int. 2007 Jun;71(12):1215-22. Epub 2007 May 9. Review.PMID: 17495867 [PubMed - indexed for MEDLINE]Related articles

    10.

    Statins in the prevention of cardiovascular events in patients with renal failure.

    Buemi M, Floccari F, Nostro L, Campo S, Caccamo C, Sturiale A, Aloisi C, Giacobbe MS, Frisina N.

    Cardiovasc Hematol Disord Drug Targets. 2007 Mar;7(1):7-13. Review.PMID: 17346123 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Dyslipidemia as a therapeutic target for prevention of cardiovascular events and end-stage renal disease]

    Watanabe T.

    Nippon Rinsho. 2008 Sep;66(9):1761-9. Review. Japanese. PMID: 18788407 [PubMed - indexed for MEDLINE]Related articles

    12.

    Statin therapy in renal disease: harmful or protective?

    McCullough PA, Rocher LR.

    Curr Diab Rep. 2007 Dec;7(6):467-73.PMID: 18255012 [PubMed - indexed for MEDLINE]Related articles

    13.

    Statin effects in CKD: is there a "point of no return"?

    Wanner C.

    Am J Kidney Dis. 2009 May;53(5):723-5. No abstract available. PMID: 19393469 [PubMed - indexed for MEDLINE]Related articles

    14.

    The dyslipidemia of chronic renal disease: effects of statin therapy.

    Ozsoy RC, van Leuven SI, Kastelein JJ, Arisz L, Koopman MG.

    Curr Opin Lipidol. 2006 Dec;17(6):659-66. Review.PMID: 17095911 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of statins on renal function.

    Agarwal R.

    Mayo Clin Proc. 2007 Nov;82(11):1381-90. Review. Erratum in: Mayo Clin Proc. 2007 Dec;82(12):1579. PMID: 17976359 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?

    Krane V, Wanner C.

    Am J Kidney Dis. 2005 Mar;45(3):607-9. No abstract available. PMID: 15754285 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease.

    Fried LF.

    Kidney Int. 2008 Sep;74(5):571-6. Epub 2008 Jun 4. Review.PMID: 18528321 [PubMed - indexed for MEDLINE]Related articles

    18.

    [About cardiovascular risk assessment in the new clinical trials with statins]

    Martín Luján F, Baldrich Justel M, Solà Alberich R, Basora Gallisà J.

    Med Clin (Barc). 2004 Apr 17;122(14):559. Spanish. No abstract available. PMID: 15117656 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lipid abnormalities and cardiovascular risk in renal disease.

    Ritz E, Wanner C.

    J Am Soc Nephrol. 2008 Jun;19(6):1065-70. Epub 2008 Mar 27. Review.PMID: 18369085 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Management of dyslipidemias in patients with diabetes and chronic kidney disease.

    Molitch ME.

    Clin J Am Soc Nephrol. 2006 Sep;1(5):1090-9. Epub 2006 Jul 26. Review.PMID: 17699330 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity